Benjamin Tomlinson clinical trial pipeline

2 trials changed in the last 30 days: 0 stopped, 0 with notable changes, 2 with minor changes only.

1. Minor

   Decitabine and Venetoclax Treatment as Maintenance Therapy in…Decitabine and Venetoclax Treatment as Maintenance Therapy in Patients Post Allograft Stem Cell Transplant

   Primary completion pushed from Dec 2026 to Mar 2027

   Also in this update: Study completion pushed from Jul 2027 to Sep 2027

   Benjamin Tomlinson·Phase 1/2· NCT06129734· Registry history of NCT06129734 on ClinicalTrials.gov (opens the registry)

   Oct 8, 2026

2. Minor

   AntiCD19 Chimeric Antigen Receptor T Cells for Relapsed or…AntiCD19 Chimeric Antigen Receptor T Cells for Relapsed or Refractory Lymphoid Malignancies

   Primary completion date changed from estimate of Sep 1, 2025 to Dec 11, 2025

   Also in this update: Study completion pushed from Dec 1, 2039 to Dec 1, 2040

   Benjamin Tomlinson·Phase 1· NCT04732845· Registry history of NCT04732845 on ClinicalTrials.gov (opens the registry)

   Sep 23, 2026

• Stopped: an ongoing trial was terminated, suspended or withdrawn.
• Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
• Minor: routine progress and housekeeping, such as sites added or enrollment closed.